Prelude Capital Management’s Semler Scientific SMLR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-40,605
Closed -$1.34M 1446
2022
Q4
$1.34M Buy
40,605
+8,608
+27% +$299K 0.07% 298
2022
Q3
$1.2M Buy
31,997
+3,200
+11% +$121K 0.04% 367
2022
Q2
$811K Buy
28,797
+9,363
+48% +$335K 0.02% 605
2022
Q1
$963K Buy
19,434
+8,769
+82% +$588K 0.03% 610
2021
Q4
$977K Sell
10,665
-9,760
-48% -$1.09M 0.03% 633
2021
Q3
$2.55M Buy
+20,425
New +$2.58M 0.07% 233

Other funds holding SMLR

Prelude Capital Management's SMLR Position: Q1 2023 in Review

Prelude Capital Management sold out of Semler Scientific (SMLR) in Q1 2023, closing a stake of 40,605 shares — an estimated $1.34M sold.

Prelude Capital Management first reported a position in SMLR in Q3 2021 and held it in 6 quarters. The position peaked at $2.55M in Q3 2021. 74 funds tracked by Wall St. Rank hold SMLR as of Q1 2023.

  • Prelude Capital Management reported no remaining Semler Scientific position as of Q1 2023 after selling out during the quarter.
  • Prelude Capital Management sold 40,605 Semler Scientific shares in Q1 2023, an estimated $1.34M.
  • Prelude Capital Management first reported a position in Semler Scientific in Q3 2021 and held it in 6 quarters.
  • Prelude Capital Management's Semler Scientific position peaked at $2.55M in Q3 2021.
  • 74 funds tracked by Wall St. Rank held Semler Scientific as of Q1 2023.

Based on Prelude Capital Management's 13F filing for Q1 2023, filed 15 May 2023.